These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 11187421)
21. Cardiovascular effects of insulin sensitizers in diabetes. Jawa A; Fonseca V Curr Opin Investig Drugs; 2006 Sep; 7(9):806-14. PubMed ID: 17002258 [TBL] [Abstract][Full Text] [Related]
22. [Evaluation of a thiazolidinedione compound as a new antidiabetic drug]. Toyota T Nihon Rinsho; 2001 Nov; 59(11):2211-8. PubMed ID: 11712410 [TBL] [Abstract][Full Text] [Related]
23. Troglitazone: a review of its use in the management of type 2 diabetes mellitus. Plosker GL; Faulds D Drugs; 1999 Mar; 57(3):409-38. PubMed ID: 10193691 [TBL] [Abstract][Full Text] [Related]
24. Long-term cardiovascular effects of insulin sensitizer troglitazone on non-diabetic individuals with insulin resistance: double blind, prospective randomized study. Stakos DA; Schuster DP; Sparks EA; Wooley CF; Osei K; Boudoulas H J Cardiol; 2003 Apr; 41(4):183-90. PubMed ID: 12728539 [TBL] [Abstract][Full Text] [Related]
25. Potential cardiovascular benefits of insulin sensitizers. Kunhiraman BP; Jawa A; Fonseca VA Endocrinol Metab Clin North Am; 2005 Mar; 34(1):117-35. PubMed ID: 15752925 [TBL] [Abstract][Full Text] [Related]
30. New oral therapies for type 2 diabetes mellitus: The glitazones or insulin sensitizers. Mudaliar S; Henry RR Annu Rev Med; 2001; 52():239-57. PubMed ID: 11160777 [TBL] [Abstract][Full Text] [Related]
31. A review of metabolic and cardiovascular effects of oral antidiabetic agents: beyond glucose-level lowering. Ginsberg H; Plutzky J; Sobel BE J Cardiovasc Risk; 1999 Oct; 6(5):337-46. PubMed ID: 10534139 [TBL] [Abstract][Full Text] [Related]
32. Glitazones: clinical effects and molecular mechanisms. Stumvoll M; Häring HU Ann Med; 2002; 34(3):217-24. PubMed ID: 12173692 [TBL] [Abstract][Full Text] [Related]
33. Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials. Krentz AJ; Bailey CJ; Melander A BMJ; 2000 Jul; 321(7256):252-3. PubMed ID: 10915108 [No Abstract] [Full Text] [Related]
34. Thiazolidinediones--tools for the research of metabolic syndrome X. Komers R; Vrána A Physiol Res; 1998; 47(4):215-25. PubMed ID: 9803467 [TBL] [Abstract][Full Text] [Related]
35. Troglitazone action is independent of adipose tissue. Burant CF; Sreenan S; Hirano K; Tai TA; Lohmiller J; Lukens J; Davidson NO; Ross S; Graves RA J Clin Invest; 1997 Dec; 100(11):2900-8. PubMed ID: 9389757 [TBL] [Abstract][Full Text] [Related]